Advocacy Fact Sheet: Hepatitis B Policy Priorities
![Hepatitis B Policy Priorities (pdf)](/sites/default/files/styles/thumbnail/public/images/publications/advocacy_fact_sheet_hep_b_policy_priorities.png?itok=jQcVkej5)
Although hepatitis B is preventable and treatable, there is still no cure for this disease. In addition to the devastating toll on patients and their families, ignoring hepatitis B costs the U.S. an estimated $4 billion per year in medical costs. Yet, the NIH will spend only $66 million in FY 2021...